Juan M. Leon-Borreguero

Santa Cruz De Tenerife, CN 38320, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Use of artificial intelligence to assess genetic predisposition to develop critical COVID-19 disease: a comparative study of machine learning models.

Use of artificial intelligence to assess genetic predisposition to develop critical COVID-19 disease: a comparative study of machine learning models.

Journal: Advances in laboratory medicine

Published: August 30, 2024

Title Not Found

Title Not Found

Journal: Advances in laboratory medicine

Published: August 30, 2024

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

Journal: World neurosurgery

Published: March 15, 2019

Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

Journal: World neurosurgery

Published: November 30, 2018

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

Journal: BMC neurology

Published: November 13, 2018

Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.

Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.

Journal: Journal of critical care

Published: September 11, 2018

Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients.

Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients.

Journal: Clinical chemistry and laboratory medicine

Published: November 10, 2016

Serum caspase 3 levels are associated with early mortality in severe septic patients.

Serum caspase 3 levels are associated with early mortality in severe septic patients.

Journal: Journal of critical care

Published: November 09, 2015

Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.

Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.

Journal: BMC neurology

Published: September 02, 2015

Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.

Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.

Journal: International journal of molecular sciences

Published: March 14, 2015

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.

Journal: PloS one

Published: February 25, 2015

Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Journal: BMC neurology

Published: February 16, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026